Long-term administration of desferrioxamine in thalassaemia major

No abstract is available for this paper.

• Publication year

  1974

• Venue

  Archives of Disease in Childhood

• Publication date

  1974-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/adc.49.8.621PMID 4278421PMCID PMC1648977
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urinary iron excretion in thalassaemia after desferrioxamine administration

  1974cited by this paper
• Proceedings: 5-year controlled trial of chelating agents in treatment of thalassaemia major.

  1973cited by this paper
• Serum-immunoglobulin levels in thalassaemia and the effects of splenectomy.

  1971cited by this paper
• EXcretion and distribution of iron during chronic deferoxamine therapy.

  1971cited by this paper
• Storage iron and desferrioxamine.

  1970cited by this paper
• Iron Balance and its Disorders

  1970cited by this paper
• Clinical usefulness of iron chelating agents.

  1969cited by this paper
• Clinical usefulness of iron chelating agents.

  1969cited by this paper
• Iron excretion in thalassemia after the administration of chelating agents.

  1969cited by this paper
• SOME CLINICAL FEATURES OF COOLEY'S ANEMIA PATIENTS AS RELATED TO TRANSFUSION SCHEDULES

  1969cited by this paper
• CLINICAL EXPERIENCE WITH INTENSIVE TRANSFUSION THERAPY IN COOLEY'S ANEMIA *

  1969cited by this paper
• Desferrioxamine in thalassaemia.

  1968cited by this paper
• Deferoxamine and diethylenetriaminepentaacetic acid (DTPA) in thalassemia.

  1966cited by this paper
• Application of atomic absorption spectrophotometry in the determination of iron in urine.

  1965cited by this paper
• Diagnosis of iron storage disease with desferrioxamine (Desferal test).

  1964cited by this paper
• Late Cardiac Complications of Chronic, Severe, Refractory Anemia with Hemochromatosis

  1964cited by this paper
• Transfusion Hemochromatosis in Cooley's Anemia *

  1964cited by this paper
• EVALUATION OF DEFEROXAMINE IN IRON OVERLOAD.

  1964cited by this paper
• [On urinary iron].

  1962cited by this paper
• Iron Excretion in Thalassaemia Major After Administration of Chelating Agents

  1962cited by this paper
• Iron Excretion in Thalassaemia Major After Administration of Chelating Agents

  1962cited by this paper
• Generalized siderosis with fibrosis of liver and pancreas in Cooley's (Mediterranean) anemia; with observations on the pathogenesis of the siderosis and fibrosis.

  1954cited by this paper

• Cardiac complications in thalassemia throughout the lifespan: Victories and challenges

  2023cites this paper
• Cardiac Arrhythmias , and Their Management in b-Thalassemia Major Patients

  2016cites this paper
• Electrocardiographic Presentation, Cardiac Arrhythmias, and Their Management in β‐Thalassemia Major Patients

  2016cites this paper
• Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload

  2013cites this paper
• Electrocardiographic consequences of cardiac iron overload in thalassemia major

  2012cites this paper
• Iron chelation therapy associated with improvement of hematopoiesis in transfusion‐dependent patients

  2010cites this paper
• Transfusion haemosiderosis inspite of regular use of desferrioxamine: case report.

  2004cites this paper
• Effect of iron chelation on severity of ocular inflammation in an animal model.

  1986cites this paper
• Effect of an iron-chelating agent on lymphocyte proliferation.

  1984cites this paper
• Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent

  1984cites this paper
• The present status of chelating agents in medicine.

  1983cites this paper
• [Monitoring and appraisal of the effects of blood transfusion and iron chelation in thalassemia major].

  1982cites this paper
• Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload

  1981cites this paper
• Enhancement of iron chelation by desferrioxamine entrapped in red blood cell ghosts.

  1981cites this paper
• [Treatment and prevention of chronic iron overload (author's transl)].

  1981cites this paper
• DECREASING IRON STORES DURING INTENSIVE CHELATION THERAPY *

  1980cites this paper
• Clinical management of thalassemia. Decreasing iron stores during intensive chelation therapy.

  1980cites this paper
• [Treatment of iron overload due to repeated transfusions with subcutaneous infusions of desferrioxamine (author's transl)].

  1980cites this paper
• [Experience with desferrioxamine treatment by intravenous administration, in thalassemia].

  1979cites this paper
• Mechanism of Desferrioxamine‐Induced Iron Excretion in Thalassaemia

  1979cites this paper
• [Therapy of thalassemias].

  1979cites this paper
• Determinants of fecal and urinary iron excretion in desferrioxamine-treated rats.

  1978cites this paper
• [Controlled desferrioxamine treatment of congenital anaemia and transfusion siderosis (author's transl)].

  1978cites this paper
• Mechanism of iron chelation in the hypertransfused rat: definition of two alternative pathways of iron mobilization.

  1978cites this paper
• Iron overload: clinical and pathologic aspects in pediatrics.

  1977cites this paper
• Treatment of iron overload in adults with continuous parenteral desferrioxamine.

  1977cites this paper
• Total management of thalassaemia major.

  1977cites this paper
• Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload.

  1976cites this paper
• Reassessment of the use of desferrioxamine B in iron overload.

  1976cites this paper
• Day-transfusion centre for patients with thalassaemia major.

  1975cites this paper
• HYPOPARATHYROIDISM AND OTHER ENDOCRINE DYSFUNCTION COMPLICATING THALASSAEMIA MAJOR

  1975cites this paper
• Management of thalassaemia major.

  1971cites this paper